About this trial
Prospective, interventional cohort study of drug-induced sleep endoscopy (DISE) to evaluate the upper airway in a cohort of obstructive sleep apnea (OSA) surgical patients. This study has investigated the reliability of this technique, demonstrating moderate-substantial interrater and test-retest reliability. This research has also compared DISE findings to those of the lateral cephalogram X-ray and examined DISE findings in individuals who have not responded to previous sleep apnea surgery. These papers have been published and available through PubMed. Additional research is ongoing, with examination of DISE findings, comparison to other evaluation techniques, and the association between DISE findings and surgical outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients with OSA considering surgical treatment
Disqualifiers
Minors
Pregnant women
Patients unable to provide informed consent in English themselves
Prisoners
Trial design
Single group
Treatments tested in this trial
Propofol sedation
DrugPatients receive an intravenous propofol infusion titrated to reach a target level of sedation, sleep with arousability to verbal stimuli.
Treatment groups
Trial outcomes
Primary outcomes
Association between DISE and physical examination; between DISE and polysomnogram results; between DISE and awake Mueller maneuver; between DISE and lateral cephalometry; and between DISE findings and surgical outcomes
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of California, Los Angeles
Lead sponsor
National Institutes of Health (NIH)
Collaborator
American Academy of Otolaryngology-Head and Neck Surgery Foundation
Collaborator